Abstract

Bronchiectasis, sometimes referred to as non-cystic fibrosis bronchiectasis (NCFB), is a chronic lung disease in which one or more bronchi become permanently dilated, resulting in mucus retention and airway inflammation [1]. It is characterised by repeated infective exacerbations and bacterial colonisation. In bronchiectasis, Pseudomonas aeruginosa is a significant pathogen, associated with increased mortality and acute hospital admission [2]. P. aeruginosa is an aerobic Gram-negative rod-shaped bacterium and a common nosocomial pathogen [3].